Multiple human papillomavirus infections and type competition in men

Journal of Infectious Diseases

Volumn 205, Issue 1, 2012, Pages 72-81

  Rositch, Anne F ^a   Poole, Charles ^b   Hudgens, Michael G ^b   Agot, Kawango ^d   Nyagaya, Edith ^d   Moses, Stephen ^d   Snijders, Peter J F ^e   Meijer, Chris J L M ^e   Bailey, Robert C ^f   Smith, Jennifer S ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Epidemiology ^*  (United States)

^c IL   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; KENYA; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UNCIRCUMCISED MEN; WART VIRUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; BAYES THEOREM; COINFECTION; CROSS-SECTIONAL STUDIES; DNA, VIRAL; GENOTYPE; HUMANS; KENYA; MALE; MICROBIAL INTERACTIONS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 84555187482     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir709     Document Type: Article

References (50)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9. (Pubitemid 29406813)
2. Bosch FX, Lorincz A, Munoz N, Meijer C, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-65. (Pubitemid 34293391)
3. Smith JS, Backes DM, Hudgens MG, et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer 2010; 126:572-7.
4. Lajous M, Mueller N, Cruz-Valdez A, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005; 14: 1710-6. (Pubitemid 40995084)
5. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008; 17:2036-43.
6. Hernandez BY, Wilkens LR, Zhu X, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008; 197:787-94. (Pubitemid 351417000)
7. Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14: 1528-33. (Pubitemid 40807357)
8. Ng'ayo MO, Bukusi E, Rowhani-Rahbar A, et al. Epidemiology of human papillomavirus infection among fishermen along Lake Victoria shore in the Kisumu district, Kenya. Sex Transm Infect 2008; 84: 62-6.
9. Nielson CM, Harris RB, Flores R, et al. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 2009; 18:1077-83.
10. Shin HR, Franceschi S, Vaccarella S, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004; 190:468-76. (Pubitemid 38982082)
11. Gray RH, Serwadda D, Kong X, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis 2010; 201:1455-62.
12. Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 45-52. (Pubitemid 32106043)
13. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001; 64:550-9. (Pubitemid 32613745)
14. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15:1274-80. (Pubitemid 44125281)
15. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 viruslike particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364:1757-65. (Pubitemid 39488060)
16. Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-14.
17. Romanowski B, de Borba PC, Naud PS, et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009; 374:1975-85.
18. Munoz N,Manalastas R Jr, PitisuttithumP, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, doubleblind trial. Lancet 2009; 373:1949-57.
19. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New Engl J Med 2011; 364:401-11.
20. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6:271-8. (Pubitemid 40590263)
21. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121:621-32. (Pubitemid 46986496)
22. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 2003; 348:518-27. (Pubitemid 36159887)
23. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001; 184:1508-17. (Pubitemid 33139735)
24. Mendez F, Munoz N, Posso H, et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005; 192:1158-65. (Pubitemid 41368414)
25. Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transmi Dis 2003; 30:581-7. (Pubitemid 36828984)
26. Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182:1097-102.
27. Mejlhede N, Bonde J, Fomsgaard A.High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 2009; 117:108-14.
28. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003; 12:1029-37. (Pubitemid 37310259)
29. Oliveira LH, Rosa ML, Cavalcanti SM. Patterns of genotype distribution in multiple human papillomavirus infections. Clin Microbiol Infect 2008; 14:60-5. (Pubitemid 350226572)
30. Nielsen A, Kjaer SK, Munk C, Iftner T. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Trans Dis 2008; 35:276-82. (Pubitemid 351619532)
31. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195:1582-9. (Pubitemid 46799215)
32. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: metaanalysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202:1789-99.
33. Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59: 630-2.
34. Smith JS, Moses S, Hudgens MG, et al. Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis 2007; 34:928-34. (Pubitemid 350287510)
35. Smith JS, Moses S, Hudgens MG, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 2010; 201:1677-85.
36. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-56. (Pubitemid 46281312)
37. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP51/61 PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40:779-87. (Pubitemid 34208623)
38. Snijders PJ, van den Brule A, Jacobs MV, Pol RP, Meijer CJ. HPV DNA detection and typing in cervical scrapes by general primer GP51/61 PCR. In: Davy CE, Doorbar J, eds. Methods in molecular medicine: human papillomavirusesdmethods and protocols. Totowa, NJ: Humana Press2005; 101-14.
39. Witte JS, Greenland S, Haile RW, Bird CL. Hierarchical regression analysis applied to a study of multiple dietary exposures and breast cancer. Epidemiology 1994; 5:612-21. (Pubitemid 24336513)
40. Greenland S. Principles of multilevel modelling. Int J Epidemiol 2000; 29:158-67. (Pubitemid 30119722)
41. Greenland S, Poole C. Empirical-Bayes and semi-Bayes approaches to occupational and environmental hazard surveillance. Arch Environ Health 1994; 49:9-16. (Pubitemid 24063934)
42. Mejlhede N, Pedersen BV, Frisch M, Fomsgaard A. Multiple human papilloma virus types in cervical infections: competition or synergy? APMIS 2010; 118:346-52.
43. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183:8-15. (Pubitemid 32043036)
44. Dillner J, Arbyn M, Dillner L. Translational mini-review series on vaccines: monitoring of human papillomavirus vaccination. Clin Exp Immunol 2007; 148:199-207. (Pubitemid 46591311)
45. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006; 194:1044-57. (Pubitemid 44547644)
46. Chaturvedi AK, Myers L, Hammons AF, et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005; 14: 2439-45. (Pubitemid 41437849)
47. Vaccarella S, Franceschi S, Snijders PJ, Herrero R,Meijer CJ, PlummerM. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010; 19:503-10.
48. Spinillo A, Dal Bello B, Alberizzi P, et al. Clustering patterns of human papillomavirus genotypes in multiple infections. Virus Res 2009; 142:154-9.
49. Greenland S, Robins JM. Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 1991; 2:244-51.
50. Greenland S. A semi-Bayes approach to the analysis of correlated multiple associations, with an application to an occupational cancermortality study. Stat Med 1992; 11:219-30.